Alpha Cognition (ACOG) Assets Average (2024 - 2026)
Alpha Cognition (ACOG) posted quarterly Assets Average of $63.0 million for Q4 2025, up 126.0% year-over-year from $27.9 million in Q4 2024, and up 37.85% quarter-over-quarter from $45.7 million in Q3 2025.
Alpha Cognition (ACOG) Assets Average (2024 - 2026) Analysis & Trends
Alpha Cognition's Assets Average history runs 2 years deep, the most recent figure standing at $63.0 million for Q4 2025.
- In Q4 2025, Assets Average rose 126.0% year-over-year to $63.0 million; the TTM figure through Dec 2025 stood at $63.0 million (up 126.0% YoY), while the FY2025 annual figure was $65.2 million, up 145.29% from the prior year.
- Assets Average for Q4 2025 stood at $63.0 million, up from $45.7 million in the prior quarter.
- The five-year high for Assets Average was $63.0 million in Q4 2025, with the low at $3.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | Alpha Cognition | 209.03 Mn | 167.59 Mn | 5.70 Mn | 72.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.13 Mn |
| Dec 31, 2025 | 63.02 Mn |
| Sep 30, 2025 | 45.71 Mn |
| Jun 30, 2025 | 46.87 Mn |
| Mar 31, 2025 | 49.67 Mn |
| Dec 31, 2024 | 27.88 Mn |
| Sep 30, 2024 | 3.56 Mn |